The move aside, omicron AB.1 edition. New COVID-19 cases in the U.S. continue to decline, and deaths and hospitalizations are way down. But the decline in new cases is not nearly as sharp as it was two weeks ago – just 12 percent, compared with 43 percent in mid-March. And some states, including New York, are now reporting an increase in new cases.

All of this comes as omicron AB.2, a subvariant of its predecessor and more infectious, has emerged as the dominant variant in the U.S. This happened earlier this year in Europe and in Asia – and cases in both regions subsequently soared. Public health officials are bracing for a possible rebound in cases here at home.

But are we ready? Experts worry that Americans have moved on from the pandemic before it is done with us and that the U.S. could be unprepared for a new wave. Across the country, states and localities are shuttering mass vaccination and testing sites – both vaccination rates and testing are way down.

“We’re in this phase of this pandemic where we’re transitioning,” Aubree Gordon, an infectious disease epidemiologist at the University of Michigan, told the New York Times. “It’s still really critical that testing is readily available – you can’t know what’s going on if you’re not looking at it.”

Meanwhile, Congress has been unable to agree on additional COVID-19 relief and time grows short. If Congress fails to act, the consequences will be increasingly severe. Providers already have stopped treating COVID-19 patients without insurance – beginning next week, they will no longer be able to offer vaccinations free of charge.

Without action, shipments of monoclonal antibodies to states will increasingly be scaled back. The Biden Administration warns it will need to cut back its planned purchases of preventative treatments for the immunocompromised, creating a shortage of these life-saving treatments for the people who need them most. If another surge does occur and more doses of vaccines are needed, the country will no longer be able to provide enough boosters for all Americans. We will have significantly reduced testing capacity, curtailed efforts to accelerate research into next-generation vaccines, and harmed our ability to help vaccinate hundreds of millions of people in poorer countries, a step needed to stop the pandemic in its tracks.

You can help. Write Congress. Tell them to get to work and protect America – and the world.

You can share these numbers on Facebook and Twitter.